On the genesis and prognosis of variant translocations in chronic myeloid leukemia-Reference-Cited by-同舟云学术

On the genesis and prognosis of variant translocations in chronic myeloid leukemia

Published:2007-03 Issue:2 Volume:173 Page:97-106
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Gorusu Madhavi,Benn Peter,Li Zihai,Fang Min

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference47 articles.

1. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining;Rowley;Nature,1973

2. Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia;Huret;Hum Genet,1990

3. Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML;Dobrovic;Leukemia,1991

4. Translocation of c-abl to “masked” Ph in chronic myeloid leukemia;Hagemeijer;Cancer Genet Cytogenet,1985

5. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive;Yehuda;Cancer Genet Cytogenet,1999

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia;Oncohematology;2024-09-01

2. Variant Philadelphia Chromosome in Nine Cases of Chronic Myeloid Leukemia: Experience of a Tertiary Care Hospital in Eastern India;The Journal of Medical Sciences;2024-07-30

3. Novel Four-Way Variant Translocation, t(1;9;22;16)(q21;q34;q11.2;q24), in a Patient with Chronic Myeloid Leukemia;Diagnostics;2024-01-30

4. Three-way Philadelphia Translocation [t(46, XX, t(9;22;16) (q34;q11.2;q24)] in Chronic Myeloid Leukemia: A Report of Two Cases with Review of the Literature;Journal of Cancer Research and Therapeutics;2024-01-22

5. Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report;Current Oncology;2022-10-28